TWD 47.1
(-1.26%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 282.53 Million TWD | -21.27% |
2022 | 358.86 Million TWD | -36.96% |
2021 | 569.22 Million TWD | -2.93% |
2020 | 586.38 Million TWD | 1174.74% |
2019 | 46 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 442.57 Million TWD | 9.6% |
2024 Q1 | 403.82 Million TWD | 42.93% |
2023 Q4 | 282.53 Million TWD | -19.31% |
2023 FY | 282.53 Million TWD | -21.27% |
2023 Q3 | 350.16 Million TWD | -15.04% |
2023 Q2 | 412.17 Million TWD | 2.07% |
2023 Q1 | 403.82 Million TWD | 12.53% |
2022 Q3 | 317.41 Million TWD | 0.0% |
2022 FY | 358.86 Million TWD | -36.96% |
2022 Q4 | 358.86 Million TWD | 13.06% |
2021 FY | 569.22 Million TWD | -2.93% |
2020 FY | 586.38 Million TWD | 1174.74% |
2019 FY | 46 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Allied Biotech Corporation | 910.11 Million TWD | 68.956% |
Easywell Biomedicals, Inc. | 589.98 Million TWD | 52.111% |
TTY Biopharm Company Limited | 3.36 Billion TWD | 91.613% |
Synmosa Biopharma Corporation | 3.62 Billion TWD | 92.212% |
Orient EuroPharma Co., Ltd. | 6.64 Billion TWD | 95.751% |
Center Laboratories, Inc. | 6.78 Billion TWD | 95.836% |
Tien Liang BioTech Co., Ltd. | 161.05 Million TWD | -75.433% |
Orient Pharma Co., Ltd. | 892.18 Million TWD | 68.332% |
InnoPharmax Inc. | 48.64 Million TWD | -480.768% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 320.99 Million TWD | 11.98% |
Excelsior Biopharma Inc. | 472.87 Million TWD | 40.251% |
DV Biomed Co., Ltd. | 765.87 Million TWD | 63.109% |
Foresee Pharmaceuticals Co., Ltd. | 616.93 Million TWD | 54.203% |
Handa Pharmaceuticals, Inc. | 280.88 Million TWD | -0.59% |
UniPharma Co., Ltd. | 37.4 Million TWD | -655.429% |
Anxo Pharmaceutical Co., Ltd. | 1.01 Billion TWD | 72.173% |
Alar Pharmaceuticals Inc. | 76.08 Million TWD | -271.326% |
Winston Medical Supply Co., Ltd. | 373.87 Million TWD | 24.43% |
Mercury Biopharmaceutical Corporation | 49.72 Million TWD | -468.247% |
Bioray Biotech Co., Ltd | 108.75 Million TWD | -159.8% |
TSH Biopharm Corporation Limited | 133.62 Million TWD | -111.439% |